Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00177541
Other study ID # 5R01AG020629-02
Secondary ID 5R01AG020629-02
Status Completed
Phase N/A
First received September 13, 2005
Last updated August 4, 2017
Start date February 2004
Est. completion date September 2016

Study information

Verified date August 2017
Source University of Pittsburgh
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To determine the mechanisms mediating the therapeutic efficacy of pelvic floor muscle exercises and biofeedback for urge urinary incontinence, as well as the characteristics of patients most likely to respond. By identifying the key components of this treatment, we hope to simplify it and make it more easily applicable, more effective, less expensive, and thus more useful for people with urge incontinence in the future.


Description:

Urinary incontinence (UI) is prevalent and morbid in the elderly, and its associated costs exceed $26 billion annually. Although effective therapy exists, it is underutilized. This is particularly true for non-pharmacologic therapies, which are at least as effective as drugs but safer, and recommended as the initial approach by every national panel. If therapies such as biofeedback (which targets pelvic muscles and detrusor suppression) are to become more widely used, they will require simplification, fewer and briefer sessions, less expensive equipment, and less sophisticated therapists. Unfortunately, such protocols cannot yet be devised because it is unknown which components are essential. We postulate that the mechanisms mediating effectiveness can be identified and that such knowledge will make it possible to enhance efficacy and to formulate more feasible and cost-effective protocols. Since reduction in UI correlates weakly with improved quality of life, however, it is important that biofeedback's impact on life quality be assessed concomitantly to ensure that formulation of such streamlined methods does not eliminate components essential for improved quality of life, even if they have no physiological correlates. We will address these issues by treating at least 150 elderly subjects with urge UI in an 8-week course of biofeedback. We will collect clinical and quality of life data and perform extensive physiologic testing on each subject at baseline and 8 weeks later. Improvement will be correlated with change in physiologic and quality of life parameters to identify the parameters that likely mediated it. Knowledge from this study should identify predictors and mechanisms mediating success of biofeedback; suggest ways that it could be further improved; facilitate development of less expensive, quicker, and more feasible protocols to deliver it (potentially permitting application to less motivated or cognitively impaired patients); and shed insight into mechanisms that may even improve efficacy of other interventions.


Recruitment information / eligibility

Status Completed
Enrollment 123
Est. completion date September 2016
Est. primary completion date September 2016
Accepts healthy volunteers No
Gender Female
Age group 60 Years and older
Eligibility Inclusion Criteria:

- ambulatory women over age 60, who are incontinent at least twice weekly for 3 months despite correction of potentially reversible causes.

- urinary incontinence (urge or predominantly urge) by clinical criteria.

- able to accurately complete a voiding diary, to perform a 24-hour pad test under direction, and to undergo instruction in biofeedback.

Exclusion Criteria:

- significant mental impairment [mini mental status exam (MMSE) = 20)

- urethral obstruction

- history of bladder cancer

- spinal cord lesions

- multiple sclerosis

- pelvic radiation

- interstitial cystitis

- artificial sphincter implant

- expected to have changes in medications/doses during the trial

- medically unstable

- Patients with factors that could cause transient UI [e.g., current urinary tract infection (UTI), acute confusion] will be treated in concert with the subject's primary care provider and considered for enrollment if their UI persists.

- conditions that require endocarditis prophylaxis (such as heart valve problems or bacterial endocarditis)

- being unable to undergo fMRI because of claustrophobia or any metallic objects in the body, such pacemakers, metallic prostheses, aneurism clips or others.

Study Design


Intervention

Behavioral:
Biofeedback, pelvic floor muscle training, fMRI
Biofeedback, pelvic floor muscle training, fMRI

Locations

Country Name City State
United States Geriatric Continence Research Unit, NE547 Montefiore UPMC Pittsburgh Pennsylvania

Sponsors (3)

Lead Sponsor Collaborator
University of Pittsburgh National Institute on Aging (NIA), National Institutes of Health (NIH)

Country where clinical trial is conducted

United States, 

References & Publications (2)

Burgio KL, Locher JL, Goode PS, Hardin JM, McDowell BJ, Dombrowski M, Candib D. Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial. JAMA. 1998 Dec 16;280(23):1995-2000. — View Citation

Resnick NM. Improving treatment of urinary incontinence. JAMA. 1998 Dec 16;280(23):2034-5. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage reduction in urge incontinence episodes at 12 weeks 12 weeks
Secondary Various urodynamic parameters such as, e.g.: 12 weeks
Secondary Increase in functional bladder capacity at 12 weeks 12 weeks
Secondary Volume at first detrusor overactivity at 12 weeks 12 weeks
Secondary Improvement in QoL at 12 weeks 12 weeks
See also
  Status Clinical Trial Phase
Completed NCT01786967 - Understanding the Response to Fesoterodine Through Genetic Evaluation in the Elderly (URGE) Phase 3
Enrolling by invitation NCT01940367 - Electrical Nerve Stimulation for Overactive Bladder a Comparison of Treatments N/A
Recruiting NCT00437528 - Safety and Applicability Study of a Novel Heat Flow Sensor Unit for Measuring Urinary Bladder Capacity Phase 1
Completed NCT04525105 - SMAD2, SMAD3 AND TGF-β GENE EXPRESSION IN URGE URINARY INCONTINENCE
Terminated NCT02129816 - Bryophyllum Pinnatum Versus Solifenacin Versus Placebo for Overactive Bladder Phase 2/Phase 3
Terminated NCT01366066 - Transcutaneous Mechanical Nerve Stimulation in the Treatment of Incontinence Phase 3
Completed NCT01559389 - Incontinence & Intimate Partners: Assessing the Contribution of Treatment Phase 4
Completed NCT01166438 - Anticholinergic vs. Botox Comparison Study Phase 3
Completed NCT00909181 - Study of Topically Administered Oxybutynin Gel in Patients With Urge Incontinence Phase 3
Terminated NCT03923348 - Pelvic Floor Muscle Training With Leva System for Urge Incontinence N/A
Completed NCT01445834 - Age-stratified Outcome of Pelvic Floor Muscle Exercise for Urinary Incontinence N/A
Completed NCT00498888 - The Long Term Outcomes of Rehabilitation and Drug Treatment for in Urgency Urinary Incontinence N/A
Terminated NCT00373789 - Refractory Urge Incontinence and Botox Injections Phase 3
Recruiting NCT01737411 - Surgical vs. Medical Treatment of Urge Urinary Incontinence in Women Phase 1/Phase 2
Recruiting NCT00770406 - Intravesical Instillation of Botulinum Toxin Type A to Patients With Urge Urinary Incontinence Phase 1/Phase 2
Completed NCT00862745 - Bringing Simple Urge Incontinence Diagnosis & Treatment to Providers (BRIDGES) Phase 4
Completed NCT02311634 - A Comparison of Electrical Pudendal Nerve Stimulation and Transvaginal Electrical Stimulation for Urge Incontinence N/A
Completed NCT01672190 - Lessening Incontinence by Learning Yoga N/A
Completed NCT01619995 - Brain Imaging Plus Urodynamics to Investigate the Brain's Control of the Bladder N/A